MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Disrupted salience network dynamics in Parkinson´s disease patients with impulse control disorders

    I. Navalpotro-Gomez, J. Kim, PM. Paz-Alonso, M. Delgado-Alvarado, A. Quiroga-Varela, H. Jimenez-Urbieta, M. Carreiras, AP. Strafella, MC. Rodriguez-Oroz (San Sebastian, Spain)

    Objective: Our aim was to investigate the changes in dynamic functional connectivity in the brain of such patients, as well as the topological properties. Background:…
  • 2019 International Congress

    Progression of dopaminergic and serotonergic dysfunction related to motor and nonmotor manifestations in apathetic and non-apathetic parkinsonian patients: a 4-year longitudinal double-tracer PET study

    S. Prange, E. Metereau, H. Klinger, E. Schmitt, E. Lhommée, A. Bichon, D. Le Bars, A. Maillet, P. Pellissier, S. Meoni, E. Broussolle, A. Castrioto, P. Krack, S. Thobois (Bron, France)

    Objective: To investigate the progression of dopaminergic and serotonergic dysfunction and their relation to motor and nonmotor impairment in parkinsonian patients with or without apathy,…
  • 2019 International Congress

    Pre-frontal activation during walking in Parkinson’s disease: the impact of attention

    S. Stuart, A. Giritharan, J. Quinn, M. Mancini (Portland, OR, USA)

    Objective: This study aimed to; 1) examine pre-frontal cortex (PFC) activation during walking in response to increased attentional load (dual-task) in Parkinson’s disease (PD); and…
  • 2019 International Congress

    The neural representations of the voice tremor spectrum

    L. Xavier, K. Simonyan (Boston, MA, USA)

    Objective: Investigate shared and disorder-specific brain abnormalities in essential and dystonic tremor of voice using functional and structural brain imaging. Background: Essential tremor of voice…
  • 2019 International Congress

    Smartphone Applications Are Promising Modalities for Monitoring Parkinson’s Disease (PD) Symptoms

    M. Qazi, H. Ellsworth, J. Chou, F. Wang, N. Hellmers, C. Henchcliffe, H. Sarva (Ny, NY, USA)

    Objective: To review use of smartphone applications to monitor and manage PD. Background: Smartphone applications successfully monitor and manage chronic diseases. For patients with PD,…
  • 2019 International Congress

    Effect of deep brain stimulation on endothelial function and heart rate variability in Parkinson’s disease

    JH. Yoon, DG. Park (Suwon, Republic of Korea)

    Objective: We aimed to investigate whether deep brain stimulation (DBS) surgery could impact on the vascular endothelial function and heart rate variability in Parkinson’s disease…
  • 2019 International Congress

    Fixation suppression the easy way – when nothing else matters

    F. Gandor, M. Tesch, H. Neuhauser, D. Gruber, HJ. Heinze, G. Ebersbach, T. Lempert (Beelitz-Heilstaetten, Germany)

    Objective: to validate a simple bedside test to objectify the fixation suppression of the vestibulo-ocular reflex (FS-VOR) in patients with cerebellar syndrome Background: The FS-VOR…
  • 2019 International Congress

    Prevalence and associated risk factors of early morning off among the patients with Parkinson’s disease in China

    W. Mao, C. Han, J. An, Z. Liu, P. Chan (Beijing, China)

    Objective: To explore the prevalence and associated risk factors of early morning off (EMO) among outpatients with Parkinson’s disease (PD) in China. Background: PD is…
  • 2019 International Congress

    An explorative study on the value of clinical features for diagnosing Parkinson’s disease

    S. Suwijn, R. de Bie (Amsterdam, Netherlands)

    Objective: To investigate the usefulness of clinical features to differentiate subjects with “scans without evidence of dopaminergic deficit” (SWEDD) from patients presumed to have Parkinson’s…
  • 2019 International Congress

    Neuromelanin MRI detects monoaminergic cell loss in Huntington Disease Expansion Gene Carriers.

    ER. de Natale, H. Wilson, G. Dervenoulas, F. Niccolini, SJ. Tabrizi, M. Politis (London, United Kingdom)

    Objective: To measure, with NM-MRI, the integrity of neuromelanin-containing monoaminergic cells in the SN and LC in Huntington Disease Gene Expansion Carriers (HDGECs) and compare…
  • « Previous Page
  • 1
  • …
  • 53
  • 54
  • 55
  • 56
  • 57
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley